SCRN3 Activators
SCRN3 Activators refers to a class of chemical compounds that, through their direct or indirect interactions with ion gradients, can enhance the functional activity of SCRN3. This protein is involved in vesicle exocytosis, a process influenced by sodium, potassium, and calcium ion gradients. By blocking sodium channels, compounds like Tetrodotoxin, Quinidine, Amiloride, and Riluzole can impact these gradients, indirectly enhancing SCRN3's role in vesicle exocytosis. Similarly, Tetraethylammonium and Clofilium, as potassium channel blockers, and Verapamil and Diltiazem, as calcium channelblockers, also influence ion gradients, indirectly leading to the functional enhancement of SCRN3.
Moreover, certain compounds can alter ion gradients, contributing to the functional enhancement of SCRN3. Monensin and Nigericin, as sodium and potassium ionophores respectively, alter respective ion gradients, indirectly enhancing SCRN3's role in vesicle exocytosis. Similarly, A23187, a calcium ionophore, by altering the calcium gradient, can indirectly enhance the function of SCRN3. Bafilomycin A1, an inhibitor of the V-ATPase responsible for vesicle acidification, also indirectly enhances SCRN3's function in vesicle exocytosis by affecting vesicle pH.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker. Calcium ions play a crucial role in vesicle exocytosis, a process that SCRN3 is involved in. By blocking calcium channels, Verapamil can affect the calcium ion gradient, indirectly enhancing the function of SCRN3. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is an inhibitor of the V-ATPase, which is responsible for acidifying vesicles. SCRN3 is involved in vesicle exocytosis, and this process can be influenced by vesicle pH. By inhibiting the V-ATPase, Bafilomycin A1 can indirectly enhance the function of SCRN3. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that alters the sodium ion gradient across membranes, which can impact vesicle exocytosis, a process that SCRN3 is involved in. By altering the sodium gradient, Monensin can indirectly enhance the function of SCRN3. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
Nigericin is a potassium ionophore that can alter the potassium ion gradient across membranes. This can influence vesicle exocytosis, a process that SCRN3 is involved in. By altering the potassium gradient, Nigericin can indirectly enhance the function of SCRN3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that alters the calcium ion gradient across membranes, which can impact vesicle exocytosis, a process SCRN3 is involved in. By altering the calcium gradient, A23187 can indirectly enhance the function of SCRN3. | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $437.00 $1040.00 | 1 | |
Clofilium is a potassium channel blocker that can influence the potassium ion gradient, which impacts vesicle exocytosis, a process that SCRN3 is involved in. By blocking these channels, Clofilium can indirectly enhance the function of SCRN3. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine is a sodium channel blocker that can alter the sodium ion gradient, which influences vesicle exocytosis, a process SCRN3 is involved in. By blocking these channels, Quinidine can indirectly enhance the function of SCRN3. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is a sodium channel blocker. The sodium ion gradient can impact vesicle exocytosis, a process that SCRN3 is involved in. By blocking these channels, Amiloride can indirectly enhance the function of SCRN3. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem is a calcium channel blocker that can impact the calcium ion gradient, which influences vesicle exocytosis, a process that SCRN3 is involved in. By blocking these channels, Diltiazem can indirectly enhance the function of SCRN3. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Riluzole is a sodium channel blocker that can alter the sodium ion gradient, which influences vesicle exocytosis, a process that SCRN3 is involved in. By blocking these channels, Riluzole can indirectly enhance the function of SCRN3. | ||||||